Cardiovascular drugs: effects on exercise testing and exercise training of the coronary patient.
The exercise test response and exercise capacity of patients with atherosclerotic coronary heart disease may be significantly altered by a number of commonly used cardiovascular drugs, alone or in combination, via complex interactions of hemodynamic and electrophysiologic changes. The clinician must assess the effects of pharmacotherapy when evaluating the results of exercise testing as well as when prescribing a rehabilitative exercise training regimen.
Wenger
N K
NK
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002395:Catecholamines / Q000627:therapeutic use; D003327:Coronary Disease / Q000175:diagnosis / Q000188:drug therapy*; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004562:Electrocardiography; D005080:Exercise Test; D006801:Humans; D005996:Nitroglycerin / Q000627:therapeutic use; D005082:Physical Exertion; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D002395:Catecholamines; D004071:Digitalis Glycosides; D014665:Vasodilator Agents; D005996:Nitroglycerin